Atlas Trials

Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer

Clinical trial NCT05201729 · UNKNOWN

Trial details

NCT number
NCT05201729
Sponsor
Ruijin Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Pancreatic Ductal Adenocarcinoma, PDAC
Start date
2021-08-01
Primary completion
2022-12-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.